Guardian Investment Management Bristol Myers Squibb CO Transaction History

Guardian Investment Management

$100 Million
Q2 2025

A detailed history of Guardian Investment Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Guardian Investment Management holds 9,500 shares of BMY stock, worth $436,335. This represents 0.44% of its overall portfolio holdings.

Number of Shares

9,500

Previous 9,850 3.55%

Holding current value

$436,335

Previous $600,000 26.83%

% of portfolio

0.44%

Previous 0.49%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	SELL	$44.12 - $59.6 $15,442 - $20,860	-350 Reduced 3.55%	9,500 $439,000
Q1 2025 Apr 25, 2025	SELL	$53.9 - $63.11 $80,850 - $94,665	-1,500 Reduced 13.22%	9,850 $600,000
Q3 2024 Oct 10, 2024	SELL	$39.66 - $51.75 $23,795 - $31,050	-600 Reduced 5.02%	11,350 $587,000
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $87,543 - $115,253	-2,175 Reduced 15.4%	11,950 $496,000
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $513,385 - $582,080	-10,700 Reduced 43.1%	14,125 $765,000
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $535,364 - $638,837	-11,043 Reduced 30.79%	24,825 $1.27 Million
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $11,578 - $12,946	200 Added 0.56%	35,868 $2.08 Million
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $591,101 - $656,325	-9,278 Reduced 20.64%	35,668 $2.28 Million
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $374,284 - $424,522	5,696 Added 14.51%	44,946 $3.12 Million
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $34,240 - $40,545	-500 Reduced 1.26%	39,250 $0
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $130 - $76,840	-1,000 Reduced 2.45%	39,750 $2.83 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $37,541 - $43,764	-700 Reduced 1.69%	40,750 $2.54 Million
Q3 2021 Oct 13, 2021	SELL	$59.17 - $69.31 $650,633 - $762,132	-10,996 Reduced 20.97%	41,450 $2.45 Million
Q2 2021 Jul 14, 2021	BUY	$61.91 - $67.42 $464,325 - $505,650	7,500 Added 16.69%	52,446 $3.5 Million
Q1 2021 Apr 14, 2021	SELL	$59.34 - $66.74 $16,318 - $18,353	-275 Reduced 0.61%	44,946 $2.84 Million
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $17,322 - $19,629	-300 Reduced 0.66%	45,221 $2.81 Million
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $86,145 - $95,460	-1,500 Reduced 3.19%	45,521 $2.74 Million
Q2 2020 Jul 13, 2020	SELL	$54.82 - $64.09 $18,803 - $21,982	-343 Reduced 0.72%	47,021 $2.76 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $116,000 - $168,575	2,500 Added 5.57%	47,364 $2.64 Million
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $68,894 - $89,866	-1,400 Reduced 3.03%	44,864 $2.88 Million
Q3 2019 Oct 24, 2019	BUY	$42.77 - $50.71 $150,122 - $177,992	3,510 Added 8.21%	46,264 $2.35 Million
Q2 2019 Aug 16, 2019	BUY	$44.62 - $49.34 $22,310 - $24,670	500 Added 1.18%	42,754 $1.94 Million
Q1 2019 Apr 22, 2019	SELL	$45.12 - $53.8 $137,164 - $163,552	-3,040 Reduced 6.71%	42,254 $2.02 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $43,396 - $56,274	890 Added 2.0%	45,294 $2.35 Million
Q3 2018 Oct 19, 2018	SELL	$55.19 - $62.25 $92,388 - $104,206	-1,674 Reduced 3.63%	44,404 $2.76 Million
Q2 2018 Jul 13, 2018	BUY	$50.53 - $62.98 $328,495 - $409,432	6,501 Added 16.43%	46,078 $2.55 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $41,284 - $47,527	-689 Reduced 1.71%	39,577 $2.5 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $9,050 - $9,867	151 Added 0.38%	40,266 $2.47 Million
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $2.22 Million - $2.56 Million	40,115	40,115 $2.56 Million

Others Institutions Holding BMY

# of Institutions

2,668

Shares Held

1.58B

Call Options Held

26.1M

Put Options Held

23.8M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $97.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Investment Management with notifications on news.

Account

Guardian Investment Management Bristol Myers Squibb CO Transaction History